Human Xtensions

Human Xtensions P/B

The P/B (Price-to-Book Ratio) of Human Xtensions (HUMX-M.TA) as of Nov 5, 2026 is 1.97. In the previous year, P/B (Price-to-Book Ratio) was 0.22 — a change of 796.19% (higher).

P/B

1.97

YoY

796.19%

Last updated:

P/B (Price-to-Book Ratio) of Human Xtensions is 2024 1.97 . P/B (Price-to-Book Ratio) of Human Xtensions was 2023 0.22 . It decreases by 796.19% higher compared to the previous year.

The Human Xtensions P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
0.37 ILS
Jan 1, 2019
0.28 ILS
Jan 1, 2020
0.04 ILS
Jan 1, 2021
0.06 ILS
Jan 1, 2022
0.09 ILS
Jan 1, 2023
0.22 ILS
Jan 1, 2024
1.97 ILS
The Human Xtensions P/B history
YEARP/BYoY
1.97+796.19%
0.22+136.65%
0.09+69.20%
0.06+42.37%
0.04-86.27%
0.28-24.10%
0.37—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Human Xtensions Stock analysis

What does Human Xtensions do? Human Xtensions Ltd. develops and sells medical devices for minimally invasive surgery, including HandX, Fenestrated Gasper, Monopolar Hook, and Needle Holder. The company focuses on digital handheld devices that extend the human hand, providing surgeons with ergonomic positioning during procedures. Its products are marketed globally to healthcare providers and surgical teams seeking advanced tools for laparoscopic operations. The firm operates through its subsidiary Human Xtensions Inc. to serve international markets. The company's revenue comes from the sale of its product portfolio, with HandX being an electromechanical laparoscopic device designed for controlled surgical procedures. Fenestrated Gasper, Monopolar Hook, and Needle Holder complement the HandX system, targeting specific surgical applications. These products are sold directly to hospitals and surgical centers worldwide, with no mention of additional services or licensing agreements in the business description. Human Xtensions Ltd. serves the global medical device market, specifically focusing on minimally invasive surgical tools. The firm's products are designed to improve surgeon ergonomics and patient outcomes during laparoscopic procedures. Its subsidiary Human Xtensions Inc. supports international sales and distribution, ensuring global reach without specifying regional market segments or customer types beyond healthcare institutions. Human Xtensions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Human Xtensions stock

P/B (Price-to-Book Ratio) of Human Xtensions is 1.97 in 2024.

P/B (Price-to-Book Ratio) of Human Xtensions changed from 0.22 to 1.97, representing a 796.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Human Xtensions since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Human Xtensions with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Human Xtensions

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Human Xtensions